Mammaglobin Gene Expression: A Superior Marker of Breast Cancer Cells in Peripheral Blood in Comparison to Epidermal-Growth-Factor Receptor and Cytokeratin-19
- 1 July 2000
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 80 (7), 1071-1077
- https://doi.org/10.1038/labinvest.3780112
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Detection and Clinical Importance of Micrometastatic DiseaseJNCI Journal of the National Cancer Institute, 1999
- Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.Journal of Clinical Oncology, 1998
- Putative markers for the detection of breast carcinoma cells in bloodBritish Journal of Cancer, 1998
- Reverse transcriptase/polymerase chain reaction detection of cytokeratin-19 mRNA in bone marrow and blood of breast cancer patientsZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reactionBritish Journal of Cancer, 1995
- Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction.Journal of Clinical Oncology, 1994
- Differential Expression of Proliferation-Associated Molecules in Individual Micrometastatic Carcinoma CellsJNCI Journal of the National Cancer Institute, 1993
- Illegitimate transcription: transcription of any gene in any cell type.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.BMJ, 1987
- Long-term human breast carcinoma cell lines of metastatic origin: Preliminary characterizationIn Vitro Cellular & Developmental Biology - Plant, 1978